Arrowgrass Capital Partners (US)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-79,125
| Closed | -$4.95M | – | 228 |
|
2018
Q4 | $4.95M | Buy |
+79,125
| New | +$4.95M | 0.18% | 77 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 167 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 159 |
|
2018
Q1 | – | Sell |
-190,766
| Closed | -$13.7M | – | 185 |
|
2017
Q4 | $13.7M | Buy |
190,766
+67,193
| +54% | +$4.81M | 0.13% | 69 |
|
2017
Q3 | $10M | Buy |
123,573
+105,342
| +578% | +$8.53M | 0.07% | 118 |
|
2017
Q2 | $1.29M | Sell |
18,231
-186,393
| -91% | -$13.2M | 0.01% | 249 |
|
2017
Q1 | $13.9M | Buy |
204,624
+133,528
| +188% | +$9.07M | 0.14% | 84 |
|
2016
Q4 | $5.09M | Buy |
71,096
+11,849
| +20% | +$848K | 0.06% | 109 |
|
2016
Q3 | $4.69M | Sell |
59,247
-42,502
| -42% | -$3.36M | 0.06% | 100 |
|
2016
Q2 | $8.49M | Buy |
101,749
+40,116
| +65% | +$3.35M | 0.09% | 64 |
|
2016
Q1 | $5.66M | Buy |
+61,633
| New | +$5.66M | 0.07% | 88 |
|
2015
Q3 | – | Sell |
-2,000
| Closed | -$234K | – | 243 |
|
2015
Q2 | $234K | Buy |
+2,000
| New | +$234K | ﹤0.01% | 221 |
|
2015
Q1 | – | Sell |
-20,000
| Closed | -$1.89M | – | 245 |
|
2014
Q4 | $1.89M | Buy |
+20,000
| New | +$1.89M | 0.03% | 162 |
|
2014
Q3 | – | Hold |
0
| – | – | – | 203 |
|
2014
Q2 | – | Hold |
0
| – | – | – | 157 |
|
2014
Q1 | – | Hold |
0
| – | – | – | 159 |
|
2013
Q4 | – | Sell |
-125,000
| Closed | -$7.86M | – | 146 |
|
2013
Q3 | $7.86M | Buy |
+125,000
| New | +$7.86M | 0.29% | 57 |
|